Tandem Diabetes Care Inc
TNDM
Market Cap$1.12B
Close$
$-5.11
130.5% downside
Current Fair Value
130.5% downsideOvervalued by 130.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.12 Billion |
|---|---|
| Enterprise Value | $1.42 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.47 |
| Beta | 1.52 |
| Outstanding Shares | 66,404,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.06 |
|---|---|
| PEG | -2.95 |
| Price to Sales | 0.93 |
| Price to Book Ratio | 8.39 |
| Enterprise Value to Revenue | 1.18 |
| Enterprise Value to EBIT | -8.11 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 2.32 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Tandem Diabetes Care Inc
1,600 employees
CEO: John Sheridan Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach t...